Washington, DC - It can be an enormous challenge for schools and businesses to determine how to establish an effective COVID-19 testing program, particularly with the multiple testing options now on the market. An innovative online tool funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), part of the National Institutes of Health, helps organizations choose a COVID-19 testing strategy that will work best for their specific needs. The COVID-19 Testing Impact Calculator is a free resource that shows how different approaches to testing and other mitigation measures, such as mask use, can curb the spread of the virus in any organization. It is the first online tool in the nation to provide schools and businesses with clear guidance on risk-reducing behaviors and testing to help them stay open safely.

Washington, DC - On Friday, December 4, President Trump signed into law the Rodchenkov Act, anti-doping legislation that would add robust penalties for individuals and entities that facilitate unfair competition in international sporting events.

Washington, DC - By the authority vested in me as President by the Constitution and the laws of the United States of America, including the National Security Act of 1947, as amended, I hereby order the following:

Washington, DC - Today,(Sunday)  we celebrate the ratification of the 13th Amendment to the Constitution, which abolished slavery in our country.  One hundred and fifty-five years later, we remember the millions of souls unjustly subjected to the oppressive institution of slavery and recommit to pursuing the enduring promise of our Nation that all people have the God-given right to “Life, Liberty, and the pursuit of Happiness.”

Washington, DC - Remarks by President Trump at the Presentation of the Presidential Medal of Freedom to Dan Gable:

Washington, DC - High-dose influenza (commonly known as flu) vaccines are no better than regular-dose influenza vaccines in reducing deaths and hospitalizations among patients with underlying heart disease, according to a large study publishing in JAMA. The results do not change well-established findings about the value of an annual influenza vaccine for persons with heart disease and other chronic illnesses, and do not change the recommendation for an annual influenza vaccine for most people.